351 related articles for article (PubMed ID: 36553468)
1. Identification of Liver Fibrosis-Related MicroRNAs in Human Primary Hepatic Stellate Cells Using High-Throughput Sequencing.
Liu X; Ma H; Wu R; Wang H; Xu H; Li S; Wang G; Lv G; Niu J
Genes (Basel); 2022 Nov; 13(12):. PubMed ID: 36553468
[TBL] [Abstract][Full Text] [Related]
2. Mesenchymal stem cells improve liver fibrosis and protect hepatocytes by promoting microRNA-148a-5p-mediated inhibition of Notch signaling pathway.
Zhou Q; Rong C; Gu T; Li H; Wu L; Zhuansun X; Zhao X; Xiao Z; Kuang Y; Xu S; Wang S
Stem Cell Res Ther; 2022 Jul; 13(1):354. PubMed ID: 35883205
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-503 Targets Mothers Against Decapentaplegic Homolog 7 Enhancing Hepatic Stellate Cell Activation and Hepatic Fibrosis.
Xie X; Dou CY; Zhou Y; Zhou Q; Tang HB
Dig Dis Sci; 2021 Jun; 66(6):1928-1939. PubMed ID: 32648079
[TBL] [Abstract][Full Text] [Related]
4. Osteopontin promotes collagen I synthesis in hepatic stellate cells by miRNA-129-5p inhibition.
Chen Y; Ou Y; Dong J; Yang G; Zeng Z; Liu Y; Liu B; Li W; He X; Lan T
Exp Cell Res; 2018 Jan; 362(2):343-348. PubMed ID: 29196165
[TBL] [Abstract][Full Text] [Related]
5. SGLT2 inhibitor empagliflozin downregulates miRNA-34a-5p and targets GREM2 to inactivate hepatic stellate cells and ameliorate non-alcoholic fatty liver disease-associated fibrosis.
Shen Y; Cheng L; Xu M; Wang W; Wan Z; Xiong H; Guo W; Cai M; Xu F
Metabolism; 2023 Sep; 146():155657. PubMed ID: 37422021
[TBL] [Abstract][Full Text] [Related]
6. Human umbilical cord mesenchymal stem cells inhibit liver fibrosis via the microRNA-148a-5p/SLIT3 axis.
Yuan M; Yao L; Chen P; Wang Z; Liu P; Xiong Z; Hu X; Li L; Jiang Y
Int Immunopharmacol; 2023 Dec; 125(Pt A):111134. PubMed ID: 37918086
[TBL] [Abstract][Full Text] [Related]
7. miRNA-130b-5p promotes hepatic stellate cell activation and the development of liver fibrosis by suppressing SIRT4 expression.
Wang H; Wang Z; Wang Y; Li X; Yang W; Wei S; Shi C; Qiu J; Ni M; Rao J; Cheng F
J Cell Mol Med; 2021 Aug; 25(15):7381-7394. PubMed ID: 34272822
[TBL] [Abstract][Full Text] [Related]
8. Extracellular vesicles-derived miR-150-5p secreted by adipose-derived mesenchymal stem cells inhibits CXCL1 expression to attenuate hepatic fibrosis.
Du Z; Wu T; Liu L; Luo B; Wei C
J Cell Mol Med; 2021 Jan; 25(2):701-715. PubMed ID: 33342075
[TBL] [Abstract][Full Text] [Related]
9. Astaxanthin Attenuates the Changes in the Expression of MicroRNAs Involved in the Activation of Hepatic Stellate Cells.
Bae M; Kim MB; Lee JY
Nutrients; 2022 Feb; 14(5):. PubMed ID: 35267937
[TBL] [Abstract][Full Text] [Related]
10. miR-96-5p prevents hepatic stellate cell activation by inhibiting autophagy via ATG7.
Yu K; Li N; Cheng Q; Zheng J; Zhu M; Bao S; Chen M; Shi G
J Mol Med (Berl); 2018 Jan; 96(1):65-74. PubMed ID: 29051972
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-494-3p prevents liver fibrosis and attenuates hepatic stellate cell activation by inhibiting proliferation and inducing apoptosis through targeting TRAF3.
Li H; Zhang L; Cai N; Zhang B; Sun S
Ann Hepatol; 2021; 23():100305. PubMed ID: 33434689
[TBL] [Abstract][Full Text] [Related]
12. Bone marrow mesenchymal stem cells inhibit hepatic fibrosis via the AABR07028795.2/rno-miR-667-5p axis.
Feng Y; Li Y; Xu M; Meng H; Dai C; Yao Z; Lin N
Stem Cell Res Ther; 2022 Jul; 13(1):375. PubMed ID: 35902883
[TBL] [Abstract][Full Text] [Related]
13. Epigenetically-Regulated MicroRNA-9-5p Suppresses the Activation of Hepatic Stellate Cells via TGFBR1 and TGFBR2.
Yu F; Chen B; Fan X; Li G; Dong P; Zheng J
Cell Physiol Biochem; 2017; 43(6):2242-2252. PubMed ID: 29073595
[TBL] [Abstract][Full Text] [Related]
14. MiR-9a-5p regulates proliferation and migration of hepatic stellate cells under pressure through inhibition of Sirt1.
Qi F; Hu JF; Liu BH; Wu CQ; Yu HY; Yao DK; Zhu L
World J Gastroenterol; 2015 Sep; 21(34):9900-15. PubMed ID: 26379395
[TBL] [Abstract][Full Text] [Related]
15. miR-345-5p curbs hepatic stellate cell activation and liver fibrosis progression by suppressing hypoxia-inducible factor-1alpha expression.
Wang P; Fang Y; Qiu J; Zhou Y; Wang Z; Jiang C
Toxicol Lett; 2022 Nov; 370():42-52. PubMed ID: 36126797
[TBL] [Abstract][Full Text] [Related]
16. PGE
Brea R; Motiño O; Francés D; García-Monzón C; Vargas J; Fernández-Velasco M; Boscá L; Casado M; Martín-Sanz P; Agra N
Biochim Biophys Acta Mol Basis Dis; 2018 Feb; 1864(2):325-337. PubMed ID: 29109031
[TBL] [Abstract][Full Text] [Related]
17. Identification of miRNA-target gene regulatory networks in liver fibrosis based on bioinformatics analysis.
Tai Y; Zhao C; Gao J; Lan T; Tong H
PeerJ; 2021; 9():e11910. PubMed ID: 34434654
[TBL] [Abstract][Full Text] [Related]
18. miRNA-150-5p promotes hepatic stellate cell proliferation and sensitizes hepatocyte apoptosis during liver fibrosis.
Chen W; Yan X; Yang A; Xu A; Huang T; You H
Epigenomics; 2020 Jan; 12(1):53-67. PubMed ID: 31833387
[No Abstract] [Full Text] [Related]
19. MiRNA/mRNA network topology in hepatitis virus B-related liver cirrhosis reveals miR-20a-5p/340-5p as hubs initiating fibrosis.
Yao H; Li P; Xin J; Liang X; Jiang J; Shi D; Li J; Hassan HM; Chen X; Li J
BMC Med Genomics; 2022 Nov; 15(1):240. PubMed ID: 36376845
[TBL] [Abstract][Full Text] [Related]
20. Identification of miR-199a-5p, miR-214-3p and miR-99b-5p as Fibrosis-Specific Extracellular Biomarkers and Promoters of HSC Activation.
Messner CJ; Schmidt S; Özkul D; Gaiser C; Terracciano L; Krähenbühl S; Suter-Dick L
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
